HIATL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.937600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.472800E-01
Normal-vs-Stage2
9.507600E-01
Normal-vs-Stage3
9.961500E-02
Normal-vs-Stage4
7.042200E-01
Stage1-vs-Stage2
4.182400E-01
Stage1-vs-Stage3
2.957800E-01
Stage1-vs-Stage4
3.674400E-01
Stage2-vs-Stage3
8.881600E-02
Stage2-vs-Stage4
6.093600E-01
Stage3-vs-Stage4
1.564990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.496800E-01
Normal-vs-AfricanAmerican
8.464800E-01
Normal-vs-Asian
9.778200E-01
Caucasian-vs-AfricanAmerican
6.387400E-01
Caucasian-vs-Asian
8.593400E-01
AfricanAmerican-vs-Asian
8.187200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.486400E-01
Normal-vs-Female
9.382600E-01
Male-vs-Female
5.918400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.856760E-01
Normal-vs-Age(41-60Yrs)
5.600200E-01
Normal-vs-Age(61-80Yrs)
7.964600E-01
Normal-vs-Age(81-100Yrs)
6.191800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.351800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.829000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.742800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.082800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.065700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.040400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.642200E-01
Normal-vs-Daily Drinker
6.684400E-01
Normal-vs-Weekly Drinker
9.311200E-01
Normal-vs-Occasional Drinker
6.780000E-01
Normal-vs-Social Drinker
9.814600E-01
Non Drinker-vs-Daily Drinker
9.802400E-01
Non Drinker-vs-Weekly Drinker
5.043400E-01
Non Drinker-vs-Occasional Drinker
9.224300E-02
Non Drinker-vs-Social Drinker
3.691600E-01
Daily Drinker-vs-Weekly Drinker
5.302200E-01
Daily Drinker-vs-Occasional Drinker
1.184600E-01
Daily Drinker-vs-Social Drinker
3.920200E-01
Weekly Drinker-vs-Occasional Drinker
3.725400E-01
Weekly Drinker-vs-Social Drinker
8.537600E-01
Occasional Drinker-vs-Social Drinker
4.266000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.511200E-01
Normal-vs-Grade 2
3.712400E-02
Normal-vs-Grade 3
4.518200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.878700E-03
Grade 1-vs-Grade 3
3.157800E-02
Grade 1-vs-Grade 4
2.511200E-01
Grade 2-vs-Grade 3
6.824400E-01
Grade 2-vs-Grade 4
3.712400E-02
Grade 3-vs-Grade 4
4.518200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.980800E-01
Normal-vs-NonDiabetic
9.609000E-01
Diabetic-vs-NonDiabetic
2.578200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.739600E-01
Normal-vs-NoPancreatitis
9.397400E-01
Pancreatitis-vs-NoPancreatitis
4.344000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.017600E-01
Normal-vs-N1
9.459400E-01
N0-vs-N1
5.019200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.896600E-01
Normal-vs-TP53-NonMutant
7.816600E-01
TP53-Mutant-vs-TP53-NonMutant
5.938500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
